MedPath

Lactulose

LACTULOSE For Oral Solution

Approved
Approval ID

3363bdbd-f0d1-45b3-8193-7fdb0a310cc2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Foxland Pharmaceuticals, Inc.

DUNS: 079407828

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lactulose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69067-020
Application NumberANDA074712
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lactulose
Product Specifications
Route of AdministrationORAL
Effective DateApril 11, 2025
FDA Product Classification

INGREDIENTS (1)

LACTULOSEActive
Quantity: 20 g in 20 g
Code: 9U7D5QH5AE
Classification: ACTIB

Lactulose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69067-010
Application NumberANDA074712
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lactulose
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 9, 2024
FDA Product Classification

INGREDIENTS (1)

LACTULOSEActive
Quantity: 10 g in 10 g
Code: 9U7D5QH5AE
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.